Clinical trial
Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In…
NCT00174486 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00174486 |
|---|---|
| Title | Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction |
| Official title | A Double Blind, Placebo Controlled, Parallel Group, Multicenter Study To Assess The Duration Of Action, Safety And Toleration Of Differing Doses and Combinations Of Immediate and Modified Release Formulations Of UK-369,003 and Cialis Compared To Placebo In Adult Male Subjects With Erectile… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Impotence |
| Intervention type | Drug |
| Interventions | UK0369, 003, Cialis (Tadalafil) |
| Enrollment | 300 |
| Start date | Feb 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 25, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: